Commonwealth Bank of Australia’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Commonwealth Bank of Australia’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-18,866	Closed	-$565K	–	1203
2014 Q1	$565K	Buy	18,866 +6,966	+59%	+$240K	﹤0.01%	1004
2013 Q4	$361K	Sell	11,900 -20,500	-63%	-$565K	﹤0.01%	1102
2013 Q3	$1.03M	Sell	32,400 -21,300	-40%	-$489K	0.01%	743
2013 Q2	$811K	Buy	+53,700	New	+$744K	0.01%	786

Other funds holding NPSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Commonwealth Bank of Australia's NPSP Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of NPS PHARMACEUTICALS INC (NPSP) in Q2 2014, closing a stake of 18,866 shares — an estimated $565K sold.

Commonwealth Bank of Australia first reported a position in NPSP in Q2 2013 and held it in 4 quarters. The position peaked at $1.03M in Q3 2013. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

Commonwealth Bank of Australia reported no remaining NPS PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 18,866 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $565K.
Commonwealth Bank of Australia first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
Commonwealth Bank of Australia's NPS PHARMACEUTICALS INC position peaked at $1.03M in Q3 2013.
215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.